Skip to main content
Bachem Holding AG logo

Bachem Holding AG — Investor Relations & Filings

Ticker · BANB ISIN · CH1176493729 LEI · 506700S81111XI7TG884 SW Manufacturing
Open in API
Filings indexed 28 across all filing types
Latest filing 2025-07-24 Earnings Release
Country CH Switzerland
Listing SW BANB

About Bachem Holding AG

https://www.bachem.com/

Bachem is a technology company specializing in the development and manufacturing of peptides and oligonucleotides. As a contract development and manufacturing organization (CDMO), it provides a comprehensive range of products and services to the pharmaceutical and biotechnology industries. The company supports clients throughout the entire product lifecycle, from research and clinical development to commercial application. Its portfolio includes active pharmaceutical ingredients (APIs) as New Chemical Entities (NCEs) and generics, as well as an extensive catalog of research-grade products such as catalog peptides, amino acid derivatives, and custom synthesis services. Bachem also offers its expertise for cosmetic and diagnostic applications.

Recent filings

Filing Released Lang Actions
Bachem mit starkem Wachstum im ersten Halbjahr 2025
Earnings Release Classification · 100% confidence The document is a press release (Medienmitteilung) dated July 24, 2025, detailing the financial performance for the first half of 2025 ('erstes Halbjahr 2025'). It provides key metrics like sales (CHF 313.0 Mio.) and EBITDA (CHF 91.0 Mio.) for the period, along with an updated outlook for the full year 2025 and targets for 2026. This content structure—a summary of period results, key performance indicators, management commentary, and outlook—is characteristic of an Earnings Release (ER). Although it mentions the full 'Halbjahresbericht 2025' is available elsewhere, this document itself is the initial announcement of those results, making 'ER' the most appropriate classification over 'IR' (Interim Report) or 'RPA' (Report Publication Announcement). The length (7672 chars) is substantial enough to be the primary release, not just a notification. H1 2025
2025-07-24 German
Bachem mourns the loss of company founder Dr. h.c. Peter Grogg
Regulatory Filings Classification · 99% confidence The document is a 'Media Release' announcing the death of the company founder, Peter Grogg. It details his history with the company, quotes the current Chairman, and provides standard company boilerplate and contact information. This type of announcement, concerning the passing of a key figure, does not fit the definitions for financial reports (10-K, IR, ER), corporate actions (CAP, SHA, DIV), or specific regulatory filings (DVA, DIRS). It is an announcement regarding personnel/governance changes, but specifically about a deceased founder, not a current management change (MANG) or remuneration (DEF 14A). Since it is a general, non-financial, non-regulatory announcement that doesn't fit the highly specific categories, the most appropriate fallback is 'Regulatory Filings' (RNS), as it is a formal public communication. However, upon reviewing the definitions, 'Board/Management Information (MANG)' covers 'Announcement of changes in the company's board of directors or senior management.' While the founder is deceased, this is a significant change related to the company's leadership history and structure. Given the context of corporate filings, announcements regarding key leadership figures, even posthumously, often fall under management/governance updates. Since the document is a formal press release about a major figure associated with the board and management, MANG is a slightly better fit than the general RNS fallback, although RNS remains a possibility if MANG is strictly interpreted as only *current* changes. Given the context of a major figure's passing, MANG is selected as the most relevant category for leadership-related news.
2025-06-03 English
Bachem trauert um Firmengründer Dr. h.c. Peter Grogg
Board/Management Information Classification · 95% confidence The document is titled "Medienmitteilung" (Media Release) and announces the death of the company founder, Dr. h.c. Peter Grogg. It provides biographical details, quotes from the Chairman of the Board, and contact information for Media and Investor Relations. This type of announcement, concerning a significant event like the passing of a founder or executive, falls under changes in management/board structure or general corporate news. Given the options, 'Board/Management Information' (MANG) is the most appropriate fit as it relates to a key figure (founder, former CEO, and Honorary Chairman) of the company. It is not a formal financial filing (like 10-K, IR, ER) nor a presentation (IP). Since it is a specific announcement about a key person, MANG is preferred over the general fallback RNS.
2025-06-03 German
Bachem increases sales and profitability
Earnings Release Classification · 100% confidence The document is titled 'Ad hoc announcement' and presents key financial highlights for the fiscal year 2024, including sales, EBITDA, net income, and dividend proposals. It explicitly states that the full 'Annual Report 2024 can be viewed and downloaded on the Bachem website' and provides a link. This structure—a summary of annual results with a reference to the full report—is characteristic of an Earnings Release (ER). Although it covers the full year, it is not the comprehensive 10-K filing itself, but rather the initial announcement of the results. The document also contains a financial calendar mentioning the AGM and the future publication of the Annual Report 2025, further confirming its nature as a current period results announcement. FY 2024
2025-02-27 English
Bachem erhöht Umsatz und Profitabilität
Earnings Release Classification · 100% confidence The document is a press release ("Medienmitteilung") detailing the full-year financial results for 2024, including revenue, EBITDA, EBIT, and net profit figures. It also provides an outlook for 2025 and 2026. This content structure—a summary of key financial metrics for a completed period, issued via press release—is characteristic of an Earnings Release (ER). Although it contains comprehensive results, the format is that of an initial announcement rather than a full, detailed regulatory filing like a 10-K or a comprehensive Interim Report (IR). The mention of the upcoming General Assembly (30. April 2025) confirms this relates to the recently concluded fiscal year (2024). Therefore, ER is the most appropriate classification. FY 2024
2025-02-27 German
Bachem with slight sales growth in the first half of 2024. Outlook confirmed for full year.
Report Publication Announcement Classification · 99% confidence The document explicitly mentions 'half year documents', provides key financial highlights for the 'first half of 2024' (Sales, EBITDA, Net Income), and includes a CEO quote on the results for the 'first half of the year'. This strongly indicates it is an announcement related to interim financial results. The document is short, apologizes for website overload, and provides direct download links for the 'Half-Year Report' and 'Presentation'. According to Rule 2 (The 'MENU VS MEAL' Rule), when a document is short and announces the availability of a full report (like the Half-Year Report), it should be classified as a Report Publication Announcement (RPA) rather than the full Interim Report (IR) itself. The content is an announcement summarizing the results and pointing to the full report.
2024-07-25 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.